Towards an Artificial Pancreas:
An FDA-NIH-JDRF Workshop
On July 21-22, JDRF co-hosted a workshop with the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) that focused on the state of the art in the research and development of an artificial pancreas.  The two-day workshop brought together some of the world's top scientists, regulators, industry representatives, and others with a connection to type 1 diabetes to discuss the progress and remaining challenges in the development of closed-loop systems that will automatically regulate blood sugar in people with diabetes. 

The sessions dramatically highlighted advances that have been made since the previous conference in December 2005 in tying together continuous glucose monitors and insulin pumps with sophisticated algorithms to replicate the function of a human pancreas, including ongoing human clinical trials, the development of complex algorithms that ensure these next generation devices will be both safe and effective, and the creation of an in silico model of type 1 diabetes in humans, that can speed clinical trial testing of proposed control algorithms. 

JDRF is making information from the FDA-NIH-JDRF workshop available to the public.  Presentations by the scientists are linked below.  A conference report will be available in a few weeks -- click here to receive a free copy.  In addition, the event was webcast live via http://videocast.nih.gov/, and will soon be available in an archived form.

Introductory Remarks		State of the Art: Designs and results from the Latest Closed Loop Studies, Part 1
State of the Art: Designs and results from the Latest Closed Loop Studies, Part 2		State of the Art: Designs and results from the Latest Closed Loop Studies, Part 3
Defining Success and Failure: Appropriate Measures, Part 1		Defining Success and Failure: Appropriate Measures, Part 2
Algorithms: State of the Art and Future Directions, Part 1		Algorithms: State of the Art and Future Directions, Part 2
Engineering and Patient Considerations When Building a Closed Loop System

Welcome and First Day Impressions

• Judith Fradkin, M.D., Director, Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, NIH

From Automated Insulin Delivery to an Artificial Pancreas: How We Get There, Part 1		From Automated Insulin Delivery to an Artificial Pancreas: How We Get There, Part 2
Beyond Insulin Dependent Diabetes, Part 1		Beyond Insulin Dependent Diabetes, Part 2
Beyond Insulin Dependent Diabetes, Part 3

Wrap Up

• Hylton V. Joffe, M.D., M.M.Sc., Center for Drug Evaluation and Research, Food and Drug Administration
  
  
  

  Disclaimer